Subscribe to RSS - ResMed


Talk up home sleep testing


Even though HME providers can’t conduct home sleep tests themselves, at least not when Medicare is the payer, they should still be very much vested in the success of the market, vendors say.

ResMed expands research facility


DUBLIN – ResMed plans to add 50 new jobs to its research, development and innovation facility, according to reports.

‘Pieces coming together’ for HST


YARMOUTH, Maine – 2012 could end up being a watershed year for home sleep testing (HST), say vendors that have large stakes in the market.

M&A scene: Harmar, ResMed, ATG


SARASOTA, Fla. – The Cortec Group, a New York-based private equity investment firm, has acquired Harmar Mobility. The transaction closed July 20, according to a press release from Harris Williams & Co., an investment bank that advised Harmar.

ResMed posts ‘solid’ fiscal year results


SAN DIEGO – ResMed officials, during an earnings call Aug. 2, downplayed competitive bidding and a new re-supply rule, saying neither would have much impact on the company.

ResMed buys compliance tool


SAN DIEGO – ResMed announced today that it has acquired Umbian, developer of U-Sleep, a software program that allows HME providers to obtain and manage compliance data from any major CPAP device.

In brief: Stakeholders organize, OIG investigates


WASHINGTON – Industry stakeholders last week submitted comments to CMS outlining concerns with a recent wave of claims against surety bonds—some triggered by overpayments as low as $16. The stakeholder, which include the Wayne van Halem Group, U.S.

In brief: Bill to repeal device tax gains ground, OMB seeks comments on PMD demo


WASHINGTON – A bill to repeal a 2.3% tax on medical devices cleared the Ways and Means Committee in the House of Representatives last week, but industry stakeholders aren’t getting their hopes up.

In brief: F&P boosts profits, ResMed launches in Japan


AUCKLAND, New Zealand – Fisher & Paykel Healthcare says expanding clinical applications for its medical devices and new products contributed to record operating revenue of NZ$516.7 million for the year ended March 31, 2012.

Home sleep therapy market starts to grow up


At some point a young, growing business market will reach maturity—it is inevitable. Whether this is the case with home sleep therapy remains to be seen, but signs are pointing in that direction.